z-logo
Premium
Vasoactive effects of P2X7 receptors in the aorta of control and hypertensive mice
Author(s) -
Howarth Amelia Rose,
Menzies R.I.,
Conway B.R.,
Bailey M.A.
Publication year - 2017
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.31.1_supplement.lb822
Subject(s) - electrical impedance myography , endocrinology , medicine , urotensin ii , vascular smooth muscle , vasoconstriction , renovascular hypertension , receptor , kidney , aorta , purinergic receptor , thoracic aorta , endothelium , vasodilation , smooth muscle
P2X7 receptors (P2X7R) are activated by extracellular ATP and have well defined pro‐inflammatory roles in immune cells. The receptor is also expressed in the vascular endothelium and we recently reported that systemic infusion of a P2X7R antagonist reduced blood pressure and increased renal perfusion in hypertensive rats (Menzies et al, Kidney International, 88, p1079, 2015). In the present study we performed a comprehensive immunlocalisation study of P2X7R expression in the mouse renal vasculature and examined the effect of P2X7R activation on the contractility of isolated aorta. Kidneys from male C57BL6 mice were fixed and P2X7R immunofluorescence performed using a rabbit anti‐P2X7 primary antibody (Alomone, 1:500). Immunofluorescence staining was also performed using antibodies against CD31 (endothelium marker); αSMA (vascular smooth muscle marker) and PDGFRβ (pericyte marker). This approach localised P2X7 to the endothelium of mouse renal arteries and glomerular capillaries, but not to the vascular smooth muscle. P2X7 was also seen to co‐localise with PDGFRβ at focal points in the renal medulla. To examine the functional role of vascular P2XR7 expression, we performed wire myography on thoracic aorta dissected from male C57BL6 mice (n=5). The P2X7R agonist, BzATP (50μM) induced a modest vasoconstriction, amounting to 20±5.2% of that induced by depolarisation with KCL. Preincubation with the P2X7R antagonist A438079 (10μM), blocked ~70% of the BZATP‐induced constriction. In a separate group of mice, we induced hypertension (Hypertensive mice: 136.5±3.2mmHg Control mice: 113.3±1.9mmHg) through a 4 week administration of ANGII (100ng/kg/min) and deoxycorticosterone (50mg), combined with high salt feeding. This regimen induced perivascular fibrosis but no albuminuria. In this setting, BZATP also induced a constriction, similar to that observed in non‐treated mice. However, pre‐incubation with the P2X7R antagonist amplified the constrictive response to BZATP. Our data confirm endothelial expression of P2X7R innormotensive mice and suggest that activation of the receptor exerts a modest vasoconstriction. In hypertensive animals, our data suggest that P2X7R exerts a vasodilatory tone. Support or Funding Information This work has been generously funded by the British Heart Foundation

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here